Degenerative photoreceptor (PR) cells contribute to vision loss in AMD patients. The lack of effective models to study PR repair and maintenance is a critical gap in our knowledge, limiting current therapeutic strategies to prevent retinal damage and reinstate vision in AMD. Previous data revealed an ATF6-dependent loss of cone PR outer segments (OS), correlated to dysfunctional mitochondria and loss of critical ciliogenesis genes. While ATF6’s role in mitochondrial health and OS formation is not characterized, its pharmacological modulation shows promise in repairing cone PR function in AMD. We hypothesize that that ATF6’s transcriptional network directly regulates cone PR OS formation by improving mitochondrial health and upregulating essential ciliogenesis genes. We aim to define ATF6-dependent mitochondrial defects in AMD relevant retinal cell types (RPE, PR, RGC, Müller glia) and investigate changes in mitochondria morphologies and function (Aim 1.1). ATF6-dependent targets, such as RAB23, MARS2, OPA2, which have a critical role in mitochondrial stability, will be confirmed through biochemical and molecular analysis. Using ATF6 control and mutant retinal organoids, we will evaluate ciliogenesis components and perform rescue experiments using ATF6 activators to elucidate their therapeutic potential (Aim 1.2). Electron and confocal microscopy, along with patch clamp recordings, will assess functionality in newly generated cone PR cells. Aim 2; using the bi-foveated, cone-rich brown anole lizard, we created atf6 Mutant lizards, confirming the absence of cone PR OS. Advanced imaging will examine cone PR OS and foveal morphology. Retinal analysis includes a characterization of all AMD-affected cell types through biochemical and molecular data collection, with bulk RNAseq analysis in progress (NovoGen). The atf6-dependent rescue of lizard cone PR OS’s in Mut animals will be assessed through micro-injection of AV[atf6(N)] into the intravitreal space. Strong collaborations assist with OCT, AOSLO images, and ERG readings. Our research combines stem cell technologies and the lizard model to explore an alternative regulatory mechanism for cone OS development and regeneration using the ATF6 transcriptome. Alongside current AMD therapies like RPE cell replacement, our project offers a potentially synergistic approach to treat AMD pathologies.
Funder: Brightfocus Foundation
Amount: $449,986
PI: Heike Kroeger, Franklin College of Arts and Sciences, Department of Cellular Biology